Further research will now be required to determine whether ERO1α also impacts on other pathways such as PI3K-AktmTOR signalling which are frequently activated in pancreatic cancer and known to modulate cell proliferation, protein production, genomic stability, cellular metabolism, and metastatic potential. Here, ERO1A is linked to familial pancreatic carcinoma.